Subscribe To
Krystal clear: krystal biotech clears resistance in good volume
Last week, shares of the Pittsburgh-based genetic medicines developer surged more than 25% after the FDA approved its therapy for a rare skin disease ...
May 30, 2023, 7:36 am
Steve cohen's point72 disclosed 8.7% stake in elevation oncology
Elevation Oncology NASDAQ: ELEV is a biotech company that focuses on discovering and developing cancer ...
May 30, 2023, 6:56 am
Immunic to participate in scientific and investor conferences in june
NEW YORK , May 30, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered,...
May 30, 2023, 6:30 am
2 growth stocks that doubled in 2023 and could shoot 55% to 87% higher, according to wall street
Two stocks in the healthcare sector have already doubled this year, and they could climb much higher, according to Wall Street. Viking Therapeutics is...
May 30, 2023, 5:38 am
Specialty enzymes market size worth usd 3.27 billion by 2032 at 6.82% cagr – report by market research future (mrfr)
Specialty Enzymes Market Trends and Insights By Source (Plants, Microorganisms, Animal), By Application (Pharmaceuticals, Diagnostics, Biotechnology r...
May 29, 2023, 2:35 pm
Recursion pharmaceuticals is going big on ai. here's why it could be worth buying
Recursion Pharmaceuticals just acquired a pair of AI-related biotechs. This could bolster its drug discovery capabilities and better help its clients....
May 29, 2023, 8:45 am
Is spdr s&p biotech etf (xbi) a strong etf right now?
Launched on 01/31/2006, the SPDR S&P biotech ETF (XBI) is a smart beta exchange traded fund offering br...
May 29, 2023, 7:34 am
Bbh: a solid choice for biotech exposure
There are several choices for investors interested in biotech exposure through an ETF. Data analysis sh...
May 27, 2023, 5:44 am
Pds biotechnology: promising interim hnscc data reaffirms investment prospects
PDS Biotech's Phase 2 study shows potential breakthrough in treating HPV16-positive head and neck cancer. The study shows a 87.1% 12-month survival ra...
May 27, 2023, 3:40 am
Pfizer, moderna hit with new alnylam patent lawsuits over covid-19 vaccines
biotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday against Pfizer Inc and Moderna...
May 26, 2023, 4:55 pm
Lyra therapeutics announces $50.0 million private placement
WATERTOWN, Mass., May 26, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotech...
May 26, 2023, 11:57 am
Cathie wood goes bargain hunting: 3 stocks she just bought
UiPath, Prime Medicine, and Adaptive Biotechnologies were all on the Ark Invest shopping list on Thursday. Wood was particularly hungry for UiPath, ad...
May 26, 2023, 9:45 am
2 biotech stocks that could help set you up for life
Axsome has two approved treatments as well as candidates in late-stage development Vertex has the dominant treatment for cystic fibrosis and is develo...
May 26, 2023, 9:37 am
Pds biotech (pdsb) up 32% on interim data from hpv cancer study
PDS Biotech's (PDSB) shares gain as it announces encouraging interim data from the VERSATILE-002 study for treating HPV16-positive cancer patients....
May 26, 2023, 9:35 am
Should you invest in the first trust nyse arca biotechnology etf (fbt)?
Launched on 06/19/2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad expo...
May 26, 2023, 7:34 am
3 biotech stocks sitting on huge-upside catalysts
Now is a great time to start accumulating top biotech stocks. The ...
May 26, 2023, 6:19 am
U.s. presidential candidate ramaswamy takes potshot at desantis bitcoin remark
Bitcoin has suddenly found itself at the center of campaign trash-talking and chest-thumping ahead of the 2024 U.S. presidential election. Biotech-ent...
May 26, 2023, 12:14 am
Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a
– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...
May 25, 2023, 9:15 pm
Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a
– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...
May 25, 2023, 9:15 pm
Nj’s newest life sciences and biotech hub announced by onyx equities
Onyx Equities and Machine Investment Group announced plans for the Northeast Science and Technology (NEST) Center in Kenilworth. Read Full Story at so...
May 25, 2023, 6:44 pm